Subvariant patterns are in flux, with BA.5 Omicron lineages still dominant, but XBB.1.5 gaining ground.
Conservative physicians were five times more likely than their peers to say that they would treat a hypothetical COVID-19 patient with hydroxychloroquine.
All genomes belonged to the existing 123 Pango lineage, demonstrating no persistently dominant SARS-CoV-2 variants or new strains.
Infectious disease information from CIDRAP.
COVID-19 discussion & analysis on the latest developments by Dr. Osterholm and Chris Dall.
CIDRAP staff are frequently featured on other news sites. Please see our opinion pieces, commentaries, and other features.
Data on novel vaccine candidates in clinical or late preclinical development.
CIDRAP and COVID-19 podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
The Influenza Vaccines R&D Roadmap Initative
The Influenza Vaccines Roadmap provides a much-needed framework for organizing the efforts of existing influenza researchers while identifying a wide range of opportunities that will encourage new investigators to join the work.
“Trying to predict what H5N1 [avian flu] will do in the human population absolutely requires a great deal of scientific humility. I will never, ever, take H5N1 for granted. I just don’t know what it’s going to do.”
Study on masks vs N95 respirators for health workers spurs concerns
The findings suggest medical masks may offer similar protection as respirators against COVID-19, but experts say hold on.
Study says most long-COVID symptoms resolve by 1 year after mild cases, but experts not so sure
Many long-COVID patients have reported facing skepticism when seeking relief at their doctor's office.